In 2024, anti-infective medicine sales in Canada are forecast to reach $1.71 billion, with a steady annual increase of 0.58% until 2028, reaching $1.75 billion. This shows a consistent annual growth trend. The Compound Annual Growth Rate (CAGR) for 2024-2028 stands at approximately 0.58%. In 2023, the sales value for this sector was lower than the forecasts for 2024, indicating a positive evolution.
Future trends to watch for include potential market shifts due to newly emerging infectious diseases, the impact of antibiotic resistance on drug demand, and advancements in pharmaceutical technology which could spur innovation and drive sales growth.
